ANTI-OSTEOPOROSIS AND FRACTURE HEALING MARKET ANALYSIS

Anti-Osteoporosis And Fracture Healing Market, by Drug Class (Bisphosphonates (Alendronate, Risedronate, Ibandronate, Zoledronic acid), Hormone replacement therapy (Estrogen, Progestin, Others), Monoclonal Antibodies (Denosumab, Romosozumab), Anabolic Agents (Alendronate, Teriparatide), and Others), by Route of Administration (Oral and Injection), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2022-2028

Published In : Oct 2023
Code : CMI2525
Formats :
Excel and PDF
Industry : Pharmaceutical

Regional Analysis

Anti-Osteoporosis and Fracture Healing Market Regional Analysis

North America anti-osteoporosis and fracture healing market is expected to witness significant growth over the forecast period owing to new product launches. For instance, in September 2018, Zydus Pharma Inc. received approval from U.S. Food and Drug Administration (FDA) for launch of Risedronate Sodium delayed release tablets in America, a drug used for osteoporosis treatment in postmenopausal women.

In April 2018 Amgen Inc., an American biopharmaceutical company, received approval from Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for marketing of Prolia (denosumab) in Europe. Denosumab is used for treating bone loss associated with prolonged systemic glucocorticoid therapy in patients who are at increased risk of fracture. This is expected to drive the Europe anti-osteoporosis and fracture healing market growth over the forecast period.

In January 2018 Amgen Inc. and UCB S.A announced receiving approval for marketing of Evenity (romosozumab) drug in Japan by Japanese Ministry of Health, Labor and Welfare. Evenity is a bone forming agent which performs dual role of increasing bone formation and reducing bone resorption leading to reduced risk of fracture. These factors are expected to support global Anti-Osteoporosis and Fracture Healing Market growth over the forecast period.

Geographies Covered